1. Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis;Saffioti;Cochrane Database Syst Rev,2017
2. Design and endpoints for clinical trials in primary sclerosing cholangitis;Ponsioen;Hepatology,2018
3. Reflection paper on regulatory requirements for the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH),2018
4. Inter- and intra-individual variation, and limited prognostic utility, of serum alkaline phosphatase in a trial of patients with primary sclerosing cholangitis;Trivedi;Clin Gastroenterol Hepatol,2020
5. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value;de Vries;Liver Int,2016